Clinical Trials Browser

Interventional × Pituitary ACTH Hypersecretion × 30 days × Clear all

NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT04569591 2026-04-09

DDAVP for Pituitary Adenoma

Phase NA Recruiting

22 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion